This retrospective case-control study included 13,476 cases and 26,952 matched controls (N = 40,428) from a large regional health system. The population consisted of adults with hypertension. The study examined outpatient visits with blood pressure measurement, the number of antihypertensive medication ingredients, and a medication intensification score. Controls were matched on age, sex, race and ethnicity, and calendar time. The primary outcome was incident ischemic stroke. Follow-up was 2,497 (1,308) days.
Outpatient visits with blood pressure measurement per year showed that >5 visits per year were associated with lower stroke odds compared with <=1 visit. The adjusted odds ratio was 0.55 (95% CI, 0.51-0.59). Use of 2-3 antihypertensive medication ingredients was associated with reduced stroke odds compared with 0 ingredients, with an adjusted odds ratio of 0.80 (95% CI, 0.75-0.86). The highest quartile of the medication intensification score showed the strongest association with lower stroke odds, with an adjusted odds ratio of 0.47 (95% CI, 0.44-0.51).
Safety, tolerability, adverse events, serious adverse events, and discontinuations were not reported. Funding or conflicts were not reported. Findings were consistent across subgroup and sensitivity analyses. The association between hypertension care delivery and risk of incident ischemic stroke indicates that gaps in routine management may represent missed opportunities for prevention.
View Original Abstract ↓
Background: Hypertension is the leading modifiable risk factor for ischemic stroke, yet the adequacy of preventative hypertension care in routine clinical practice remains suboptimal. Whether gaps in hypertension management represent missed opportunities for stroke prevention remains unclear. Objective: To evaluate the association between hypertension care delivery and the risk of incident ischemic stroke. Methods: We conducted a retrospective, matched, nested case-control study among adults with hypertension using electronic health record data from a large regional health system (2010-2024). Patients with a first-ever ischemic stroke were matched 1:2 to controls on age, sex, race and ethnicity, and calendar time. Three care metrics were assessed during follow-up: (1) outpatient visits with blood pressure (BP) measurement per year; (2) number of antihypertensive medication ingredients; and (3) medication intensification score. Conditional logistic regression estimated adjusted odds ratios (aORs). Results: The study included 13,476 cases and 26,952 matched controls (N = 40,428). Mean (SD) age was 64.8 (12.2) years, 54.1% were female, and mean follow-up was 2,497 (1,308) days. Cases had fewer BP visits per year (median, 2.50 vs. 3.01; p < 0.001), similar number of medication ingredients (2.00 vs 2.00), and lower treatment intensification scores (-0.211 vs -0.125). In adjusted models, >5 BP visits per year was associated with lower stroke odds (aOR, 0.55; 95% CI, 0.51-0.59) compared with [≤]1 visit. Use of 2-3 medication ingredients (vs 0) was also associated with reduced stroke odds (aOR, 0.80; 95% CI, 0.75-0.86), whereas >3 ingredients was not significant. The highest quartile of treatment intensification showed the strongest association (aOR, 0.47; 95% CI, 0.44-0.51). Findings were consistent across subgroup and sensitivity analyses, including strata defined by baseline SBP and follow-up SBP. Conclusions: Greater engagement in hypertension care was associated with lower odds of ischemic stroke, suggesting that gaps in routine management may represent missed opportunities for prevention.